Introduction Microneedles are emerging as a promising technology for vaccine delivery, with
numerous advantages over traditional needle and syringe methods. Preclinical studies have …

Introduction Hexaxim is a hexavalent vaccine approved as primary and booster vaccination
in infants 6 weeks and older, protecting against diphtheria, tetanus, pertussis, poliomyelitis …

In South Korea, the ready-to-use hexavalent vaccine (against diphtheria, tetanus, pertussis,
poliovirus, Haemophilus influenzae type b, and hepatitis B) is not listed despite its facility of …

Aim The current study compared preparation time, errors, satisfaction, and preference for a
prefilled syringe (PFS) versus two RSV vaccines requiring reconstitution (VRR1 and VRR2) …

Measles and rubella micro-array patches (MR-MAPs) are a promising innovation to address
limitations of the current needle and syringe (N&S) presentation due to their single-dose …

Objective: To investigate underreporting of immunization errors based on vaccination
records from children under five years of age. Method: An epidemiological, cross-sectional …

Antimicrobial peptides and proteins (APPs) are gaining attraction as powerful agents against
multidrug-resistant bacteria. The inhalation delivery of APPs has emerged as a potent tool …

Many respiratory infections have epidemic and pandemic potential, as evidenced by
influenza and the recent COVID-19 pandemic. Vaccination is an established and effective …

Objective: To investigate underreporting of immunization errors based on vaccination
records from children under five years of age. Method: An epidemiological, cross-sectional …

Introduction Hexaxim® is fully liquid, hexavalent, combination vaccine that provides
immunization against diphtheria, tetanus, pertussis (whooping cough), polio, hepatitis B, and …